{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:03:35Z","timestamp":1790287415689,"version":"4.1.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40121-026-01324-5","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:35:10Z","timestamp":1774524910000},"page":"1149-1174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Tetracyclines in Bone and Joint Infections: A Literature Review"],"prefix":"10.1007","volume":"15","author":[{"given":"Paul","family":"Laffont-Lozes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaric","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Artiaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Loubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"1324_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ482","author":"EF Berbari","year":"2015","unstructured":"Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015. https:\/\/doi.org\/10.1093\/cid\/civ482.","journal-title":"Clin Infect Dis"},{"key":"1324_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad527","author":"\u00c9 Senneville","year":"2023","unstructured":"Senneville \u00c9, Albalawi Z, van Asten SA, Abbas ZG, Allison G, Arag\u00f3n-S\u00e1nchez J, et al. IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023). Clin Infect Dis. 2023. https:\/\/doi.org\/10.1093\/cid\/ciad527.","journal-title":"Clin Infect Dis"},{"key":"1324_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1-25. https:\/\/doi.org\/10.1093\/cid\/cis803.","journal-title":"Clin Infect Dis"},{"key":"1324_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.7150\/jbji.35428","volume":"4","author":"A Fischbacher","year":"2019","unstructured":"Fischbacher A, Borens O. Prosthetic-joint infections: mortality over the last 10 years. J Bone Jt Infect. 2019;4:198\u2013202. https:\/\/doi.org\/10.7150\/jbji.35428.","journal-title":"J Bone Jt Infect"},{"key":"1324_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1128\/aac.6.4.411","volume":"6","author":"JN Minuth","year":"1974","unstructured":"Minuth JN, Holmes TM, Musher DM. Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci. Antimicrob Agents Chemother. 1974;6:411\u20134. https:\/\/doi.org\/10.1128\/aac.6.4.411.","journal-title":"Antimicrob Agents Chemother"},{"key":"1324_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","volume":"81","author":"AK Thabit","year":"2019","unstructured":"Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO, Alhejaili SF. Antibiotic penetration into bone and joints: an updated review. Int J Infect Dis. 2019;81:128\u201336. https:\/\/doi.org\/10.1016\/j.ijid.2019.02.005.","journal-title":"Int J Infect Dis"},{"key":"1324_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jac\/dkl224","volume":"58","author":"KN Agwuh","year":"2006","unstructured":"Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother. 2006;58:256\u201365. https:\/\/doi.org\/10.1093\/jac\/dkl224.","journal-title":"J Antimicrob Chemother"},{"key":"1324_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4065\/74.7.727","volume":"74","author":"JD Smilack","year":"1999","unstructured":"Smilack JD. The tetracyclines. Mayo Clin Proc. 1999;74:727\u20139. https:\/\/doi.org\/10.4065\/74.7.727.","journal-title":"Mayo Clin Proc"},{"key":"1324_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1086\/367622","volume":"36","author":"GM Eliopoulos","year":"2003","unstructured":"Eliopoulos GM, Eliopoulos GM, Roberts MC. Tetracycline therapy: update. Clin Infect Dis. 2003;36:462\u20137. https:\/\/doi.org\/10.1086\/367622.","journal-title":"Clin Infect Dis"},{"key":"1324_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jac\/dkt374","volume":"69","author":"B-N Kim","year":"2014","unstructured":"Kim B-N, Kim ES, Oh M-D. Oral antibiotic treatment of staphylococcal bone and joint infections in adults. J Antimicrob Chemother. 2014;69:309\u201322. https:\/\/doi.org\/10.1093\/jac\/dkt374.","journal-title":"J Antimicrob Chemother"},{"key":"1324_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cid\/cir842","volume":"54","author":"B Spellberg","year":"2012","unstructured":"Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2012;54:393\u2013407. https:\/\/doi.org\/10.1093\/cid\/cir842.","journal-title":"Clin Infect Dis"},{"key":"1324_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.phrs.2011.06.010","volume":"64","author":"RA Greenwald","year":"2011","unstructured":"Greenwald RA. The road forward: the scientific basis for tetracycline treatment of arthritic disorders. Pharmacol Res. 2011;64:610\u20133. https:\/\/doi.org\/10.1016\/j.phrs.2011.06.010.","journal-title":"Pharmacol Res"},{"key":"1324_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00011-021-01435-4","volume":"70","author":"BN Platt","year":"2021","unstructured":"Platt BN, Jacobs CA, Conley CEW, Stone AV. Tetracycline use in treating osteoarthritis: a systematic review. Inflamm Res. 2021;70:249\u201359. https:\/\/doi.org\/10.1007\/s00011-021-01435-4.","journal-title":"Inflamm Res"},{"key":"1324_CR14","unstructured":"Food and Drug Administration. Doxycycline Monohydrate. FDA Drug Label. [Internet]. 2025 [cited 2026 Jan 27]. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=02aa8731-d40f-43d8-8b63-a79a0503f8db. Accessed 27 Jan 2026"},{"key":"1324_CR15","unstructured":"Food and Drug Administration. Minocycline Hydrochloride. FDA Drug Label. [Internet]. 2025 [cited 2026 Jan 27]. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=799a9871-3249-471e-b88d-5d8f7d4b96ad. Accessed 27 Jan 2026"},{"key":"1324_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40262-019-00843-4","volume":"59","author":"KA Rodvold","year":"2020","unstructured":"Rodvold KA, Burgos RM, Tan X, Pai MP. Omadacycline: a review of the clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2020;59:409\u201325. https:\/\/doi.org\/10.1007\/s40262-019-00843-4.","journal-title":"Clin Pharmacokinet"},{"key":"1324_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/cid\/ciz309","volume":"69","author":"KA Rodvold","year":"2019","unstructured":"Rodvold KA, Pai MP. Pharmacokinetics and pharmacodynamics of oral and intravenous omadacycline. Clin Infect Dis. 2019;69:16\u201322. https:\/\/doi.org\/10.1093\/cid\/ciz309.","journal-title":"Clin Infect Dis"},{"key":"1324_CR18","unstructured":"Food and Drug Administration. Tigecycline. FDA Drug Label [Internet]. 2024 [cited 2026 Jan 27]. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=acf5dbe5-ca75-4300-816f-b3f4625f6e7d. Accessed 27 Jan 2026"},{"key":"1324_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/431674","volume":"41","author":"AK Meagher","year":"2005","unstructured":"Meagher AK, Ambrose PG, Grasela TH, Ellis\u2010Grosse EJ. The pharmacokinetic and pharmacodynamic profile of tigecycline. Clin Infect Dis. 2005;41:333\u201340. https:\/\/doi.org\/10.1086\/431674.","journal-title":"Clin Infect Dis"},{"key":"1324_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2165\/00003495-197611010-00004","volume":"11","author":"PJ Neuvonen","year":"1976","unstructured":"Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs. 1976;11:45\u201354. https:\/\/doi.org\/10.2165\/00003495-197611010-00004.","journal-title":"Drugs"},{"key":"1324_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/BF02556156","volume":"48","author":"DN Misra","year":"1991","unstructured":"Misra DN. Adsorption and orientation of tetracycline on hydroxyapatite. Calcif Tissue Int. 1991;48:362\u20137. https:\/\/doi.org\/10.1007\/BF02556156.","journal-title":"Calcif Tissue Int"},{"key":"1324_CR22","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1021\/jp5116756","volume":"119","author":"S Cazalbou","year":"2015","unstructured":"Cazalbou S, Bertrand G, Drouet C. Tetracycline-loaded biomimetic apatite: an adsorption study. J Phys Chem B. 2015;119:3014\u201324. https:\/\/doi.org\/10.1021\/jp5116756.","journal-title":"J Phys Chem B"},{"key":"1324_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cclet.2007.10.048","volume":"19","author":"WC Huang","year":"2008","unstructured":"Huang WC, Zheng H, Weng LL. Synthesis of tetracycline analogs and their bone affinities. Chin Chem Lett. 2008;19:19\u201322. https:\/\/doi.org\/10.1016\/j.cclet.2007.10.048.","journal-title":"Chin Chem Lett"},{"key":"1324_CR24","doi-asserted-by":"publisher","DOI":"10.4103\/jodp.jodp_46_22","volume":"6","author":"A Singh","year":"2023","unstructured":"Singh A, Singh RK, Bimal BK, Runu R. Type of microbial flora in patients with bone and joint infections: our experience at a tertiary care center of Eastern India. J Orthop Dis Traumatol. 2023;6:58. https:\/\/doi.org\/10.4103\/jodp.jodp_46_22.","journal-title":"J Orthop Dis Traumatol"},{"key":"1324_CR25","unstructured":"EUCAST: Clinical breakpoints and dosing of antibiotics [Internet]. [cited 2024 Mar 1]. https:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed 1 Mar 2024"},{"key":"1324_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2013.01.023","volume":"76","author":"RN Jones","year":"2013","unstructured":"Jones RN, Stilwell MG, Wilson ML, Mendes RE. Contemporary tetracycline susceptibility testing: doxycycline MIC methods and interpretive criteria (CLSI and EUCAST) performance when testing Gram-positive pathogens. Diagn Microbiol Infect Dis. 2013;76:69\u201372. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.01.023.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1324_CR27","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1093\/cid\/ciu706","volume":"59","author":"M Castanheira","year":"2014","unstructured":"Castanheira M, Mendes RE, Jones RN. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options. Clin Infect Dis. 2014;59:S367\u201373. https:\/\/doi.org\/10.1093\/cid\/ciu706.","journal-title":"Clin Infect Dis"},{"key":"1324_CR28","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ijantimicag.2018.01.006","volume":"51","author":"MA Pfaller","year":"2018","unstructured":"Pfaller MA, Huband MD, Streit JM, Flamm RK, Sader HS. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016). Int J Antimicrob Agents. 2018;51:848\u201353. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.01.006.","journal-title":"Int J Antimicrob Agents"},{"key":"1324_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.diagmicrobio.2018.11.010","volume":"94","author":"AC Fluit","year":"2019","unstructured":"Fluit AC, van Gorkum S, Vlooswijk J. Minimal inhibitory concentration of omadacycline and doxycycline against bacterial isolates with known tetracycline resistance determinants. Diagn Microbiol Infect Dis. 2019;94:78\u201380. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.11.010.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1324_CR30","first-page":"42","volume":"9","author":"A Dhem","year":"1976","unstructured":"Dhem A, Piret N, Fortunati D. Tetracyclines, doxycycline and calcified tissues. Scand J Infect Dis Suppl. 1976;9:42\u20136.","journal-title":"Scand J Infect Dis Suppl"},{"key":"1324_CR31","unstructured":"Tombs NL. Tissue distribution of GAR-936, a broad-spectrum antibiotic, in male rats [abstract 413]. In: Program and abstracts of the 39th Interscience conference on antimicrobial agents and chemotherapy (San Francisco). Washington, DC. American Society for Microbiology. 1999"},{"key":"1324_CR32","first-page":"47","volume":"9","author":"K Dornbusch","year":"1976","unstructured":"Dornbusch K. The detection of doxycycline activity in human bone. Scand J Infect Dis Suppl. 1976;9:47\u201353.","journal-title":"Scand J Infect Dis Suppl"},{"key":"1324_CR33","first-page":"54","volume":"9","author":"H Gnarpe","year":"1976","unstructured":"Gnarpe H, Dornbusch K, H\u00e4gg O. Doxycycline concentration levels in bone, soft tissue and serum after intravenous infusion of doxycycline. A clinical study. Scand J Infect Dis Suppl. 1976;9:54\u20137.","journal-title":"Scand J Infect Dis Suppl"},{"key":"1324_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0300-9785(77)80001-X","volume":"6","author":"H Bystedt","year":"1977","unstructured":"Bystedt H, Dahlb\u00e4ck A, Nord C-E. Concentration of azidocillin, erythromycin, doxycycline and clindamycin in dental alveolar serum after single oral doses. Int J Oral Surg. 1977;6:65\u201374. https:\/\/doi.org\/10.1016\/S0300-9785(77)80001-X.","journal-title":"Int J Oral Surg"},{"key":"1324_CR35","first-page":"37","volume":"7","author":"H Bystedt","year":"1976","unstructured":"Bystedt H, Dornbusch K, Nord CE. Concentrations of oxytetracycline, tetracycline and doxycycline in mandibular osteitis. Scand J Infect Dis Suppl. 1976;7:37\u201341.","journal-title":"Scand J Infect Dis Suppl"},{"key":"1324_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/9781118581742.ch3","author":"CB Landersdorfer","year":"2015","unstructured":"Landersdorfer CB, Bulitta JB, S\u00f6rgel F. Pharmacokinetics and pharmacodynamics of antibiotics in bone. Bone Jt Infect. 2015. https:\/\/doi.org\/10.1002\/9781118581742.ch3.","journal-title":"Bone Jt Infect."},{"key":"1324_CR37","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200948020-00002","author":"CB Landersdorfer","year":"2009","unstructured":"Landersdorfer CB. Penetration of antibacterials into bone. Clin Pharmacokinet. 2009. https:\/\/doi.org\/10.2165\/00003088-200948020-00002.","journal-title":"Clin Pharmacokinet"},{"key":"1324_CR38","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/jac\/dkl403","volume":"58","author":"KA Rodvold","year":"2006","unstructured":"Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100-mg dose. J Antimicrob Chemother. 2006;58:1221\u20139. https:\/\/doi.org\/10.1093\/jac\/dkl403.","journal-title":"J Antimicrob Chemother"},{"key":"1324_CR39","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jpba.2008.06.020","volume":"48","author":"AJ Ji","year":"2008","unstructured":"Ji AJ, Saunders JP, Amorusi P, Wadgaonkar ND, O\u2019Leary K, Leal M, et al. A sensitive human bone assay for quantitation of tigecycline using LC\/MS\/MS. J Pharm Biomed Anal. 2008;48:866\u201375. https:\/\/doi.org\/10.1016\/j.jpba.2008.06.020.","journal-title":"J Pharm Biomed Anal"},{"key":"1324_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jcph.201","volume":"54","author":"I Bhattacharya","year":"2014","unstructured":"Bhattacharya I, Gotfried MH, Ji AJ, Saunders JP, Gourley I, Diehl A, et al. Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures. J Clin Pharmacol. 2014;54:70\u20134. https:\/\/doi.org\/10.1002\/jcph.201.","journal-title":"J Clin Pharmacol"},{"key":"1324_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3181\/00379727-130-33494","volume":"130","author":"DS Evaskus","year":"1969","unstructured":"Evaskus DS, Laskin DM, Kroeger AV. Penetration of lincomycin, penicillin, and tetracycline into serum and bone. Exp Biol Med. 1969;130:89\u201391. https:\/\/doi.org\/10.3181\/00379727-130-33494.","journal-title":"Exp Biol Med"},{"key":"1324_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-267","volume":"13","author":"CA Kreis","year":"2013","unstructured":"Kreis CA, Raschke MJ, Ro\u00dflenbroich SB, Tholema-Hans N, L\u00f6ffler B, Fuchs T. Therapy of intracellular Staphylococcus aureus by tigecyclin. BMC Infect Dis. 2013;13:267. https:\/\/doi.org\/10.1186\/1471-2334-13-267.","journal-title":"BMC Infect Dis"},{"key":"1324_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/jac\/dki109","volume":"55","author":"L-Y Yin","year":"2005","unstructured":"Yin L-Y, Lazzarini L, Li F, Stevens CM, Calhoun JH. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother. 2005;55:995\u20131002. https:\/\/doi.org\/10.1093\/jac\/dki109.","journal-title":"J Antimicrob Chemother"},{"key":"1324_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.11.006","volume":"34","author":"JM Entenza","year":"2009","unstructured":"Entenza JM, Moreillon P. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Int J Antimicrob Agents. 2009;34:8.e1-8.e9. https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.11.006.","journal-title":"Int J Antimicrob Agents"},{"key":"1324_CR45","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jinf.2014.12.016","volume":"70","author":"P Vergidis","year":"2015","unstructured":"Vergidis P, Schmidt-Malan SM, Mandrekar JN, Steckelberg JM, Patel R. Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis. J Infect. 2015;70:609\u201315. https:\/\/doi.org\/10.1016\/j.jinf.2014.12.016.","journal-title":"J Infect"},{"key":"1324_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1179\/joc.2008.20.1.53","volume":"20","author":"O Kandemir","year":"2008","unstructured":"Kandemir O, Oztuna V, Colak M, Akdag A, Camdeviren H. Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model. J Chemother. 2008;20:53\u20137. https:\/\/doi.org\/10.1179\/joc.2008.20.1.53.","journal-title":"J Chemother"},{"key":"1324_CR47","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01703-21","volume":"66","author":"MJ Karau","year":"2022","unstructured":"Karau MJ, Schmidt-Malan SM, Cunningham SA, Mandrekar JN, Pritt BS, Keepers TR, et al. Activity of omadacycline in rat methicillin-resistant Staphylococcus aureus osteomyelitis. Antimicrob Agents Chemother. 2022;66:e01703-21. https:\/\/doi.org\/10.1128\/AAC.01703-21.","journal-title":"Antimicrob Agents Chemother"},{"key":"1324_CR48","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1093\/jac\/dkz257","volume":"74","author":"A-C Cr\u00e9mieux","year":"2019","unstructured":"Cr\u00e9mieux A-C, Dinh A, Nordmann P, Mouton W, Tattevin P, Ghout I, et al. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2019;74:2666\u201375. https:\/\/doi.org\/10.1093\/jac\/dkz257.","journal-title":"J Antimicrob Chemother"},{"key":"1324_CR49","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/jor.24291","volume":"37","author":"JB Mandell","year":"2019","unstructured":"Mandell JB, Orr S, Koch J, Nourie B, Ma D, Bonar DD, et al. Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates. J Orthop Res. 2019;37:1604\u20139. https:\/\/doi.org\/10.1002\/jor.24291.","journal-title":"J Orthop Res"},{"key":"1324_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxad258","volume":"134","author":"E Perez-Alba","year":"2023","unstructured":"Perez-Alba E, Flores-Trevi\u00f1o S, Villarreal-Salazar V, Bocanegra-Ibarias P, Vilchez-Cavazos F, Camacho-Ortiz A. Planktonic and biofilm states of Staphylococcus aureus isolated from bone and joint infections and the in vitro effect of orally available antibiotics. J Appl Microbiol. 2023;134:lxad258. https:\/\/doi.org\/10.1093\/jambio\/lxad258.","journal-title":"J Appl Microbiol"},{"key":"1324_CR51","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1128\/AAC.01612-08","volume":"53","author":"P Vaudaux","year":"2009","unstructured":"Vaudaux P, Fleury B, Gjinovci A, Huggler E, Tangomo-Bento M, Lew DP. Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53:3150\u20132. https:\/\/doi.org\/10.1128\/AAC.01612-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"1324_CR52","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1139\/cjm-2015-0855","volume":"62","author":"B Ozturk","year":"2016","unstructured":"Ozturk B, Gunay N, Ertugrul BM, Sakarya S. Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model. Can J Microbiol. 2016;62:735\u201343. https:\/\/doi.org\/10.1139\/cjm-2015-0855.","journal-title":"Can J Microbiol"},{"key":"1324_CR53","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ijantimicag.2013.02.018","volume":"41","author":"D Molina-Manso","year":"2013","unstructured":"Molina-Manso D, del Prado G, Ortiz-P\u00e9rez A, Manrubia-Cobo M, G\u00f3mez-Barrena E, Cordero-Ampuero J, et al. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Int J Antimicrob Agents. 2013;41:521\u20133. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.02.018.","journal-title":"Int J Antimicrob Agents"},{"key":"1324_CR54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijantimicag.2008.08.029","volume":"33","author":"K Smith","year":"2009","unstructured":"Smith K, Perez A, Ramage G, Gemmell CG, Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents. 2009;33:374\u20138. https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.08.029.","journal-title":"Int J Antimicrob Agents"},{"key":"1324_CR55","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/jor.20902","volume":"27","author":"S Hajdu","year":"2009","unstructured":"Hajdu S, Lassnigg A, Graninger W, Hirschl AM, Presterl E. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. J Orthop Res. 2009;27:1361\u20135. https:\/\/doi.org\/10.1002\/jor.20902.","journal-title":"J Orthop Res"},{"key":"1324_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00530-19","volume":"202","author":"G Orazi","year":"2019","unstructured":"Orazi G, O\u2019Toole GA. It takes a village\u201d: mechanisms underlying antimicrobial recalcitrance of polymicrobial biofilms. J Bacteriol. 2019;202:10.1128\/jb.00530-19. https:\/\/doi.org\/10.1128\/jb.00530-19.","journal-title":"J Bacteriol"},{"key":"1324_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/mdr.2023.0186","volume":"30","author":"Y Zou","year":"2024","unstructured":"Zou Y, Li X, Mao Y, Song W, Liu Q. Enhanced biofilm formation by tetracycline in a Staphylococcus aureus naturally lacking ica operon and atl. Microb Drug Resist. 2024;30:82\u201390. https:\/\/doi.org\/10.1089\/mdr.2023.0186.","journal-title":"Microb Drug Resist"},{"key":"1324_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-024-03959-4","volume":"81","author":"AK Tooke","year":"2024","unstructured":"Tooke AK, Hodges RE, Pyrah JF, Bayles KW, Renshaw SA, Foster SJ. Tetracycline and oxacillin act synergistically on biofilms and display increased efficacy in vivo against Staphylococcus aureus. Curr Microbiol. 2024;81:447. https:\/\/doi.org\/10.1007\/s00284-024-03959-4.","journal-title":"Curr Microbiol"},{"key":"1324_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.159441","volume":"857","author":"X Hu","year":"2023","unstructured":"Hu X, Zhang Y, Chen Z, Gao Y, Teppen B, Boyd SA, et al. Tetracycline accumulation in biofilms enhances the selection pressure on Escherichia coli for expression of antibiotic resistance. Sci Total Environ. 2023;857:159441. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.159441.","journal-title":"Sci Total Environ"},{"key":"1324_CR60","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","volume":"54","author":"AN Sapadin","year":"2006","unstructured":"Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006;54:258\u201365. https:\/\/doi.org\/10.1016\/j.jaad.2005.10.004.","journal-title":"J Am Acad Dermatol"},{"key":"1324_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19127246","volume":"19","author":"M Orylska-Ratynska","year":"2022","unstructured":"Orylska-Ratynska M, Placek W, Owczarczyk-Saczonek A. Tetracyclines\u2014an important therapeutic tool for dermatologists. Int J Environ Res Public Health. 2022;19:7246. https:\/\/doi.org\/10.3390\/ijerph19127246.","journal-title":"Int J Environ Res Public Health"},{"key":"1324_CR62","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.phrs.2010.10.007","volume":"63","author":"E Monk","year":"2011","unstructured":"Monk E, Shalita A, Siegel DM. Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacol Res. 2011;63:130\u201345. https:\/\/doi.org\/10.1016\/j.phrs.2010.10.007.","journal-title":"Pharmacol Res"},{"key":"1324_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.phrs.2010.10.004","volume":"63","author":"MO Griffin","year":"2011","unstructured":"Griffin MO, Ceballos G, Villarreal FJ. Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action. Pharmacol Res. 2011;63:102\u20137. https:\/\/doi.org\/10.1016\/j.phrs.2010.10.004.","journal-title":"Pharmacol Res"},{"key":"1324_CR64","doi-asserted-by":"publisher","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","volume":"299","author":"MO Griffin","year":"2010","unstructured":"Griffin MO, Fricovsky E, Ceballos G, Villarreal F. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol-Cell Physiol. 2010;299:C539\u201348. https:\/\/doi.org\/10.1152\/ajpcell.00047.2010.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"1324_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116377","volume":"159","author":"AJ Warner","year":"2022","unstructured":"Warner AJ, Hathaway-Schrader JD, Lubker R, Davies C, Novince CM. Tetracyclines and bone: unclear actions with potentially lasting effects. Bone. 2022;159:116377. https:\/\/doi.org\/10.1016\/j.bone.2022.116377.","journal-title":"Bone"},{"key":"1324_CR66","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.phrs.2010.12.003","volume":"63","author":"J Caton","year":"2011","unstructured":"Caton J, Ryan ME. Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD). Pharmacol Res. 2011;63:114\u201320. https:\/\/doi.org\/10.1016\/j.phrs.2010.12.003.","journal-title":"Pharmacol Res"},{"key":"1324_CR67","first-page":"480","volume":"50","author":"MJ Hubbard","year":"1973","unstructured":"Hubbard MJ, Ndawula AL. A controlled trial of cloxacillin and tetracycline in chronic staphylococcal osteomyelitis in Ugandan children. East Afr Med J. 1973;50:480\u20135.","journal-title":"East Afr Med J"},{"key":"1324_CR68","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.diagmicrobio.2013.12.007","volume":"78","author":"L Lauf","year":"2014","unstructured":"Lauf L, Ozsv\u00e1r Z, Mitha I, Reg\u00f6ly-M\u00e9rei J, Embil JM, Cooper A, et al. Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis. Diagn Microbiol Infect Dis. 2014;78:469\u201380. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.12.007.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1324_CR69","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/clinids\/13.5.1023","volume":"13","author":"JH Yuk","year":"1991","unstructured":"Yuk JH, Dignani MC, Harris RL, Bradshaw MW, Williams TW. Minocycline as an alternative antistaphylococcal agent. Clin Infect Dis. 1991;13:1023\u20134. https:\/\/doi.org\/10.1093\/clinids\/13.5.1023.","journal-title":"Clin Infect Dis"},{"key":"1324_CR70","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1469-0691.2004.00928.x","volume":"10","author":"GL Pavoni","year":"2004","unstructured":"Pavoni GL, Giannella M, Falcone M, Scorzolini L, Liberatore M, Carlesimo B, et al. Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience. Clin Microbiol Infect. 2004;10:831\u20137. https:\/\/doi.org\/10.1111\/j.1469-0691.2004.00928.x.","journal-title":"Clin Microbiol Infect"},{"key":"1324_CR71","doi-asserted-by":"publisher","first-page":"110","DOI":"10.7150\/jbji.43254","volume":"5","author":"G Bart","year":"2020","unstructured":"Bart G, Zeller V, Kerroumi Y, Heym B, Meyssonnier V, Desplaces N, et al. Minocycline combined with vancomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal prosthetic joint infection managed with exchange arthroplasty. J Bone Joint Infect. 2020;5:110\u20137. https:\/\/doi.org\/10.7150\/jbji.43254.","journal-title":"J Bone Joint Infect"},{"key":"1324_CR72","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jmii.2011.01.009","volume":"44","author":"S-C Kuo","year":"2011","unstructured":"Kuo S-C, Wang F-D, Fung C-P, Chen L-Y, Chen S-J, Chiang M-C, et al. Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients. J Microbiol Immunol Infect. 2011;44:45\u201351. https:\/\/doi.org\/10.1016\/j.jmii.2011.01.009.","journal-title":"J Microbiol Immunol Infect"},{"key":"1324_CR73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jbspin.2011.05.025","volume":"79","author":"N Asseray","year":"2012","unstructured":"Asseray N, Bemer P, Corvec S, Boutoille D, Touchais S, Navas D. Tigecycline option for the treatment of bone and joint infections caused by multidrug-resistant Staphylococcus epidermidis. Joint Bone Spine. 2012;79:97\u20139. https:\/\/doi.org\/10.1016\/j.jbspin.2011.05.025.","journal-title":"Joint Bone Spine"},{"key":"1324_CR74","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.diagmicrobio.2013.07.014","volume":"77","author":"AT Griffin","year":"2013","unstructured":"Griffin AT, Harting JA, Christensen DM. Tigecycline in the management of osteomyelitis: a case series from the bone and joint infection (BAJIO) database. Diagn Microbiol Infect Dis. 2013;77:273\u20137. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.07.014.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1324_CR75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijid.2014.01.028","volume":"25","author":"J de Sanctis","year":"2014","unstructured":"de Sanctis J, Teixeira L, van Duin D, Odio C, Hall G, Tomford JW, et al. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections. Int J Infect Dis. 2014;25:73\u20138. https:\/\/doi.org\/10.1016\/j.ijid.2014.01.028.","journal-title":"Int J Infect Dis"},{"key":"1324_CR76","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s10096-016-2709-6","volume":"35","author":"PR Ingram","year":"2016","unstructured":"Ingram PR, Rawlins MDM, Murray RJ, Roberts JA, Manning L. Tigecycline use in the outpatient parenteral antibiotic therapy setting. Eur J Clin Microbiol Infect Dis. 2016;35:1673\u20137. https:\/\/doi.org\/10.1007\/s10096-016-2709-6.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1324_CR77","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2016.48.4.324","volume":"48","author":"A Vila","year":"2016","unstructured":"Vila A, Pagella H, Amadio C, Leiva A. Acinetobacter prosthetic joint infection treated with debridement and high-dose tigecycline. Infect Chemother. 2016;48:324. https:\/\/doi.org\/10.3947\/ic.2016.48.4.324.","journal-title":"Infect Chemother"},{"key":"1324_CR78","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.medmal.2017.09.001","volume":"48","author":"J Wach","year":"2018","unstructured":"Wach J, Dinh A, Dutronc H, Sipahi OR, Candevir A, Valour F, et al. Tigecycline-based prolonged salvage therapy in patients presenting with complex bone and joint infection. M\u00e9d Mal Infect. 2018;48:53\u20137. https:\/\/doi.org\/10.1016\/j.medmal.2017.09.001.","journal-title":"M\u00e9d Mal Infect"},{"key":"1324_CR79","doi-asserted-by":"publisher","first-page":"60","DOI":"10.7150\/jbji.42448","volume":"5","author":"PR Oliveira","year":"2020","unstructured":"Oliveira PR, Carvalho VC, Saconi ES, Leonhardt MC, Kojima KE, Santos JS, et al. Tigecycline versus colistin in the treatment of carbapenem-resistant Acinetobacter baumannii complex osteomyelitis. J Bone Jt Infect. 2020;5:60\u20136. https:\/\/doi.org\/10.7150\/jbji.42448.","journal-title":"J Bone Jt Infect"},{"key":"1324_CR80","doi-asserted-by":"publisher","first-page":"126","DOI":"10.7150\/jbji.34866","volume":"4","author":"A Lastinger","year":"2019","unstructured":"Lastinger A, McLeod N, Dietz MJ, Guilfoose J, Sarwari AR. Clinical experience with tigecycline in the treatment of prosthetic joint infections. J Bone Jt Infect. 2019;4:126\u201332. https:\/\/doi.org\/10.7150\/jbji.34866.","journal-title":"J Bone Jt Infect"},{"key":"1324_CR81","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijid.2014.01.027","volume":"23","author":"OR Sipahi","year":"2014","unstructured":"Sipahi OR, Kahraman H, Mermer S, Pullukcu H, Tasbakan M, Arda B, et al. Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases. Int J Infect Dis. 2014;23:16\u20139. https:\/\/doi.org\/10.1016\/j.ijid.2014.01.027.","journal-title":"Int J Infect Dis"},{"key":"1324_CR82","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3109\/23744235.2015.1062132","volume":"47","author":"D Seyman","year":"2015","unstructured":"Seyman D, Berk H, Sep\u0131n-Ozen N, K\u0131z\u0131lates F, Turk CC, Buyuktuna SA, et al. Successful use of tigecycline for treatment of culture-negative pyogenic vertebral osteomyelitis. Infect Dis. 2015;47:783\u20138. https:\/\/doi.org\/10.3109\/23744235.2015.1062132.","journal-title":"Infect Dis"},{"key":"1324_CR83","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13256-017-1357-5","volume":"11","author":"O Tsachouridou","year":"2017","unstructured":"Tsachouridou O, Georgiou A, Nanoudis S, Chrysanthidis T, Loli G, Morfesis P, et al. Prolonged and high dosage of tigecycline \u2013 successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report. J Med Case Reports. 2017;11:186. https:\/\/doi.org\/10.1186\/s13256-017-1357-5.","journal-title":"J Med Case Reports"},{"key":"1324_CR84","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s40121-022-00645-5","volume":"11","author":"T Morrisette","year":"2022","unstructured":"Morrisette T, Alosaimy S, Lagnf AM, Frens JJ, Webb AJ, Veve MP, et al. Real-world, multicenter case series of patients treated with oral omadacycline for resistant gram-negative pathogens. Infect Dis Ther. 2022;11:1715\u201323. https:\/\/doi.org\/10.1007\/s40121-022-00645-5.","journal-title":"Infect Dis Ther"},{"key":"1324_CR85","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/0377-4929.44994","volume":"52","author":"B Antony","year":"2009","unstructured":"Antony B, Thomas S, Chandrashekar SC, Kumar MS, Kumar V. Osteomyelitis of the mandible due to Aggregatibacter (Actinobacillus) actinomycetemcomitans. Indian J Pathol Microbiol. 2009;52:115\u20136. https:\/\/doi.org\/10.4103\/0377-4929.44994.","journal-title":"Indian J Pathol Microbiol"},{"key":"1324_CR86","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/01.OLQ.0000431351.50346.20","volume":"40","author":"V Boix","year":"2013","unstructured":"Boix V, Merino E, Reus S, Torrus D, Portilla J. Polyostotic osteitis in secondary syphilis in an HIV-infected patient. Sex Transm Dis. 2013;40:645. https:\/\/doi.org\/10.1097\/01.OLQ.0000431351.50346.20.","journal-title":"Sex Transm Dis"},{"key":"1324_CR87","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1097\/00007611-198412000-00044","volume":"77","author":"JP Bracikowski","year":"1984","unstructured":"Bracikowski JP, Hess IE, Rein MF. Campylobacter osteomyelitis. South Med J. 1984;77:1611\u20133. https:\/\/doi.org\/10.1097\/00007611-198412000-00044.","journal-title":"South Med J"},{"key":"1324_CR88","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/milmed\/usab350","volume":"186","author":"BW Carney","year":"2021","unstructured":"Carney BW, Rizzo JA, Alderete JF, Cindass R Jr, Markelz AE, Cancio LC. Carbapenem-resistant Enterobacterales infection after massive blast injury: use of cefiderocol based combination therapy. Mil Med. 2021;186:1241\u20135. https:\/\/doi.org\/10.1093\/milmed\/usab350.","journal-title":"Mil Med"},{"key":"1324_CR89","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s15010-012-0250-9","volume":"40","author":"JFW Chan","year":"2012","unstructured":"Chan JFW, Wong SSY, Leung SSM, Fan RYY, Ngan AHY, To KKW, et al. First report of chronic implant-related septic arthritis and osteomyelitis due to Kytococcus schroeteri and a review of human K. schroeteri infections. Infection. 2012;40:567\u201373. https:\/\/doi.org\/10.1007\/s15010-012-0250-9.","journal-title":"Infection"},{"key":"1324_CR90","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1128\/jcm.28.11.2570-2572.1990","volume":"28","author":"RB Clark","year":"1990","unstructured":"Clark RB, Spector H, Friedman DM, Oldrati KJ, Young CL, Nelson SC. Osteomyelitis and synovitis produced by Mycobacterium marinum in a fisherman. J Clin Microbiol. 1990;28:2570\u20132. https:\/\/doi.org\/10.1128\/jcm.28.11.2570-2572.1990.","journal-title":"J Clin Microbiol"},{"key":"1324_CR91","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36283","author":"R Copeland","year":"2023","unstructured":"Copeland R, Blanchard E, Saito P, Copeland R, Blanchard E, Saito P. A rare case of carpal osteomyelitis in a spinal cord injury patient: a case report. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.36283.","journal-title":"Cureus."},{"key":"1324_CR92","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/0956462414522031","volume":"25","author":"L Elopre","year":"2014","unstructured":"Elopre L, Morell V, Bosshardt C, Geisler WM. A case of syphilitic osteitis in a patient with HIV infection. Int J STD AIDS. 2014;25:765\u20137. https:\/\/doi.org\/10.1177\/0956462414522031.","journal-title":"Int J STD AIDS"},{"key":"1324_CR93","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jbspin.2010.11.010","volume":"78","author":"TM Goulenok","year":"2011","unstructured":"Goulenok TM, Bialek S, Gaudart S, B\u00e9b\u00e9ar C, Fantin B. Ureaplasma urealyticum destructive septic arthritis in a patient with systemic lupus erythematosus after rituximab therapy. Joint Bone Spine. 2011;78:323\u20134. https:\/\/doi.org\/10.1016\/j.jbspin.2010.11.010.","journal-title":"Joint Bone Spine"},{"key":"1324_CR94","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-235744","volume":"13","author":"N Gupta","year":"2020","unstructured":"Gupta N, Aggarwal A, Ramteke P, Soneja M. Mandibular osteomyelitis due to Actinomyces spp. BMJ Case Rep. 2020;13:e235744. https:\/\/doi.org\/10.1136\/bcr-2020-235744.","journal-title":"BMJ Case Rep"},{"key":"1324_CR95","first-page":"201","volume":"89","author":"I Gupta","year":"1992","unstructured":"Gupta I, Kocher J, Miller AJ, Weisholtz SJ, Perz J, Scully M. Mycobacterium haemophilum osteomyelitis in an AIDS patient. N J Med J Med Soc N J. 1992;89:201\u20132.","journal-title":"N J Med J Med Soc N J"},{"key":"1324_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4929-8","volume":"20","author":"J Hartman","year":"2020","unstructured":"Hartman J, Westerman M, Wagenaar JFP. Two-sided femoral Campylobacter jejuni osteomyelitis in a patient with acquired hypogammaglobulinemia: a case report. BMC Infect Dis. 2020;20:199. https:\/\/doi.org\/10.1186\/s12879-020-4929-8.","journal-title":"BMC Infect Dis"},{"key":"1324_CR97","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jiac.2022.04.029","volume":"28","author":"T Hayashi","year":"2022","unstructured":"Hayashi T, Mori N, Yamaguchi T, Komori K, Sugiura T, Katayama M. Invasive pectoral abscess and costal osteomyelitis with bloodstream infection caused by methicillin-resistant Staphylococcus aureus after nasal septoplasty in an immunocompetent adult patient. J Infect Chemother Off J Jpn Soc Chemother. 2022;28:1198\u2013202. https:\/\/doi.org\/10.1016\/j.jiac.2022.04.029.","journal-title":"J Infect Chemother Off J Jpn Soc Chemother"},{"key":"1324_CR98","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0266-7681_87_90082-9","volume":"12","author":"W Holms","year":"1987","unstructured":"Holms W, Ali MA. Acute osteomyelitis of index finger caused by dog bite. J Hand Surg. 1987;12:137\u20139. https:\/\/doi.org\/10.1016\/0266-7681_87_90082-9.","journal-title":"J Hand Surg"},{"key":"1324_CR99","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/os.13600","volume":"15","author":"C Huang","year":"2023","unstructured":"Huang C, Ding H, Lin Y, Zhang Z, Fang X, Chen Y, et al. Diagnosis of Coxiella burnetii prosthetic joint infection using mNGS and ptNGS: a case report and literature review. Orthop Surg. 2023;15:371\u20136. https:\/\/doi.org\/10.1111\/os.13600.","journal-title":"Orthop Surg"},{"key":"1324_CR100","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF01650712","volume":"17","author":"C Jorup-R\u00f6nstr\u00f6m","year":"1989","unstructured":"Jorup-R\u00f6nstr\u00f6m C, Ahl T, Hammarstr\u00f6m L, Smith CIE, Rylander M, Hallander H. Septic osteomyelitis and polyarthritis with ureaplasma in hypogammaglobulinemia. Infection. 1989;17:301\u20133. https:\/\/doi.org\/10.1007\/BF01650712.","journal-title":"Infection"},{"key":"1324_CR101","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1001\/archinte.1983.00350110051014","volume":"143","author":"GH Karam","year":"1983","unstructured":"Karam GH, Ackley AM, Dismukes WE. Posttraumatic Aeromonas hydrophila osteomyelitis. Arch Intern Med. 1983;143:2073\u20134. https:\/\/doi.org\/10.1001\/archinte.1983.00350110051014.","journal-title":"Arch Intern Med"},{"key":"1324_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07341-2","volume":"22","author":"T Koyama","year":"2022","unstructured":"Koyama T, Ohji G, Nishida M, Nishimura S, Shirasugi I, Ohnuma K, et al. A case report of native vertebral osteomyelitis caused by Cutibacterium modestum. BMC Infect Dis. 2022;22:367. https:\/\/doi.org\/10.1186\/s12879-022-07341-2.","journal-title":"BMC Infect Dis"},{"key":"1324_CR103","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7638639","volume":"2018","author":"SK Li","year":"2018","unstructured":"Li SK, Messer WB. Burkholderia cepacia complex cervical osteomyelitis in an intravenous drug user. Case Rep Infect Dis. 2018;2018:7638639. https:\/\/doi.org\/10.1155\/2018\/7638639.","journal-title":"Case Rep Infect Dis"},{"key":"1324_CR104","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2021.38.349.26635","author":"W Marrakchi","year":"2021","unstructured":"Marrakchi W, Aouam A, Kooli I, Brahim HB, Toumi A, Chakroun M. Cerebral nocardiosis with osteomyelitis of skull vault complicating a primary neck lesion in an immunocompetent patient: a case report. Pan Afr Med J. 2021. https:\/\/doi.org\/10.11604\/pamj.2021.38.349.26635.","journal-title":"Pan Afr Med J"},{"key":"1324_CR105","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49193","author":"R Mashiko","year":"2023","unstructured":"Mashiko R, Hatta T, Nagashima C, Mashiko R, Hatta T, Nagashima C. Periprosthetic joint infection following reverse shoulder arthroplasty treated with continuous local antibiotic perfusion: a case report. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.49193.","journal-title":"Cureus"},{"key":"1324_CR106","doi-asserted-by":"publisher","first-page":"322","DOI":"10.7883\/yoken.JJID.2021.532","volume":"75","author":"E Mori","year":"2022","unstructured":"Mori E, Hashimoto T, Yahiro T, Miura M, Ishihara T, Miyazaki M, et al. Campylobacter lari vertebral osteomyelitis. Jpn J Infect Dis. 2022;75:322\u20134. https:\/\/doi.org\/10.7883\/yoken.JJID.2021.532.","journal-title":"Jpn J Infect Dis"},{"key":"1324_CR107","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/0002-9343(70)90108-7","volume":"48","author":"RH Parker","year":"1970","unstructured":"Parker RH, Davison R, Paterson PY, Madden GM. Erythromycin-resistant pneumococcal osteomyelitis. Am J Med. 1970;48:132\u20136. https:\/\/doi.org\/10.1016\/0002-9343(70)90108-7.","journal-title":"Am J Med"},{"key":"1324_CR108","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa415","volume":"7","author":"JC Pearson","year":"2020","unstructured":"Pearson JC, Dionne B, Richterman A, Vidal SJ, Weiss Z, Vel\u00e1squez GE, et al. Omadacycline for the treatment of Mycobacterium abscessus disease: a case series. Open Forum Infect Dis. 2020;7:ofaa415. https:\/\/doi.org\/10.1093\/ofid\/ofaa415.","journal-title":"Open Forum Infect Dis"},{"key":"1324_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-11-6","volume":"11","author":"E Polilli","year":"2012","unstructured":"Polilli E, Ursini T, Mazzotta E, Sozio F, Savini V, D\u2019Antonio D, et al. Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease. Ann Clin Microbiol Antimicrob. 2012;11:6. https:\/\/doi.org\/10.1186\/1476-0711-11-6.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1324_CR110","first-page":"578","volume":"15","author":"RE Preininger","year":"1973","unstructured":"Preininger RE. Treatment of chronic staphylococcal osteomyelitis with minocycline hydrochloride: a case report. Curr Ther Res Clin Exp. 1973;15:578\u201380.","journal-title":"Curr Ther Res Clin Exp"},{"key":"1324_CR111","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/jpids\/pis110","volume":"3","author":"M Rodriguez","year":"2014","unstructured":"Rodriguez M, Nelson M, Kelly JE, Elward A, Morley SC. Successful use of Temocillin as salvage therapy for cervical osteomyelitis secondary to Multidrug-Resistant Burkholderia cepacia. J Pediatr Infect Dis Soc. 2014;3:77\u201380. https:\/\/doi.org\/10.1093\/jpids\/pis110.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"1324_CR112","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X19841465","volume":"7","author":"K Sato","year":"2019","unstructured":"Sato K, Yazawa H, Ikuma D, Maruyama T, Kajiyama H, Mimura T. Osteomyelitis due to methicillin-resistant Staphylococcus aureus successfully treated by an oral combination of minocycline and trimethoprim\u2013sulfamethoxazole. SAGE Open Med Case Rep. 2019;7:2050313X19841465. https:\/\/doi.org\/10.1177\/2050313X19841465.","journal-title":"SAGE Open Med Case Rep"},{"key":"1324_CR113","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3201\/eid1403.070128","volume":"14","author":"JJ Schafer","year":"2008","unstructured":"Schafer JJ, Mangino JE. Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq. Emerg Infect Dis. 2008;14:512\u20134. https:\/\/doi.org\/10.3201\/eid1403.070128.","journal-title":"Emerg Infect Dis"},{"key":"1324_CR114","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1099\/jmm.0.47286-0","volume":"56","author":"M Stanzani","year":"2007","unstructured":"Stanzani M, Tumietto F, Giannini MB, Bianchi G, Nanetti A, Vianelli N, et al. Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline. J Med Microbiol. 2007;56:1692\u20135. https:\/\/doi.org\/10.1099\/jmm.0.47286-0.","journal-title":"J Med Microbiol"},{"key":"1324_CR115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01203-19","volume":"64","author":"F van Wijk","year":"2019","unstructured":"van Wijk F, Waterval J, van Aerde K, Henriet SSV, Meijer FJA, Borra LC, et al. Successful systemic and topical treatment of Mycobacterium abscessus otomastoiditis. Antimicrob Agents Chemother. 2019;64:e01203-19. https:\/\/doi.org\/10.1128\/AAC.01203-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"1324_CR116","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1302\/0301-620X.60B2.659469","volume":"60-B","author":"DG Verinder","year":"1978","unstructured":"Verinder DG. Septic arthritis due to Mycoplasma hominis. A case report and review of the literature. J Bone Joint Surg Br. 1978;60-B:224\u2013224. https:\/\/doi.org\/10.1302\/0301-620X.60B2.659469.","journal-title":"J Bone Joint Surg Br"},{"key":"1324_CR117","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/00007632-199903150-00018","volume":"24","author":"K Yamashita","year":"1999","unstructured":"Yamashita K, Aoki Y, Hiroshima K. Pyogenic vertebral osteomyelitis caused by Campylobacter fetus subspecies fetus: a case report. Spine. 1999;24:582.","journal-title":"Spine"},{"key":"1324_CR118","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1128\/JCM.00787-15","volume":"53","author":"A Yoshizaki","year":"2015","unstructured":"Yoshizaki A, Takegawa H, Doi A, Mizuno Y, Nishioka H. Vertebral osteomyelitis caused by Helicobacter cinaedi. J Clin Microbiol. 2015;53:3054\u20136. https:\/\/doi.org\/10.1128\/JCM.00787-15.","journal-title":"J Clin Microbiol"},{"key":"1324_CR119","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1128\/AAC.48.6.1921-1933.2004","volume":"48","author":"JM Rolain","year":"2004","unstructured":"Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004;48:1921\u201333. https:\/\/doi.org\/10.1128\/AAC.48.6.1921-1933.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"1324_CR120","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/23744235.2020.1871508","volume":"53","author":"N Ghanem-Zoubi","year":"2021","unstructured":"Ghanem-Zoubi N, Karram T, Kagna O, Merhav G, Keidar Z, Paul M. Q fever vertebral osteomyelitis among adults: a case series and literature review. Infect Dis. 2021;53:231\u201340. https:\/\/doi.org\/10.1080\/23744235.2020.1871508.","journal-title":"Infect Dis"},{"key":"1324_CR121","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/ard.49.12.994","volume":"49","author":"MI Khateeb","year":"1990","unstructured":"Khateeb MI, Araj GF, Majeed SA, Lulu AR. Brucella arthritis: a study of 96 cases in Kuwait. Ann Rheum Dis. 1990;49:994\u20138. https:\/\/doi.org\/10.1136\/ard.49.12.994.","journal-title":"Ann Rheum Dis"},{"key":"1324_CR122","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/jpc.15304","volume":"57","author":"AP Lemos","year":"2021","unstructured":"Lemos AP, Domingues R, Gouveia C, de Sousa R, Brito MJ. Atypical bartonellosis in children: what do we know? J Paediatr Child Health. 2021;57:653\u20138. https:\/\/doi.org\/10.1111\/jpc.15304.","journal-title":"J Paediatr Child Health"},{"key":"1324_CR123","doi-asserted-by":"publisher","first-page":"S483","DOI":"10.1016\/j.arth.2018.09.034","volume":"34","author":"F Calabr\u00f2","year":"2019","unstructured":"Calabr\u00f2 F, Coen M, Franceschini M, Franco-Cendejas R, Hewlett A, Segreti J, et al. Hip and knee section, treatment, antimicrobial suppression: proceedings of International Consensus on Orthopedic Infections. J Arthroplasty. 2019;34:S483\u20135. https:\/\/doi.org\/10.1016\/j.arth.2018.09.034.","journal-title":"J Arthroplasty"},{"key":"1324_CR124","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/antibiotics4020216","volume":"4","author":"Y-P Hung","year":"2015","unstructured":"Hung Y-P, Lee J-C, Lin H-J, Liu H-C, Wu Y-H, Tsai P-J, et al. Doxycycline and tigecycline: two friendly drugs with a low association with Clostridium difficile infection. Antibiotics. 2015;4:216\u201329. https:\/\/doi.org\/10.3390\/antibiotics4020216.","journal-title":"Antibiotics"},{"key":"1324_CR125","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ijantimicag.2017.04.019","volume":"50","author":"M Pradier","year":"2017","unstructured":"Pradier M, Nguyen S, Robineau O, Titecat M, Blondiaux N, Valette M, et al. Suppressive antibiotic therapy with oral doxycycline for Staphylococcus aureus prosthetic joint infection: a retrospective study of 39 patients. Int J Antimicrob Agents. 2017;50:447\u201352. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.04.019.","journal-title":"Int J Antimicrob Agents"},{"key":"1324_CR126","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s15010-017-1077-1","volume":"46","author":"M Pradier","year":"2018","unstructured":"Pradier M, Robineau O, Boucher A, Titecat M, Blondiaux N, Valette M, et al. Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patients. Infection. 2018;46:39\u201347. https:\/\/doi.org\/10.1007\/s15010-017-1077-1.","journal-title":"Infection"},{"key":"1324_CR127","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7150\/jbji.17353","volume":"2","author":"M Wouthuyzen-Bakker","year":"2017","unstructured":"Wouthuyzen-Bakker M, Nijman JM, Kampinga GA, Assen S, Jutte PC. Efficacy of antibiotic suppressive therapy in patients with a prosthetic joint infection. J Bone Joint Infect. 2017;2:77\u201383. https:\/\/doi.org\/10.7150\/jbji.17353.","journal-title":"J Bone Joint Infect"},{"key":"1324_CR128","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7150\/jbji.37262","volume":"4","author":"B Leijtens","year":"2019","unstructured":"Leijtens B, Weerwag L, Schreurs BW, Kullberg B-J, Rijnen W. Clinical outcome of antibiotic suppressive therapy in patients with a prosthetic joint infection after hip replacement. J Bone Jt Infect. 2019;4:268\u201376. https:\/\/doi.org\/10.7150\/jbji.37262.","journal-title":"J Bone Jt Infect"},{"key":"1324_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12050937","volume":"12","author":"G Ceccarelli","year":"2023","unstructured":"Ceccarelli G, Perciballi B, Russo A, Martini P, Marchetti F, Capparuccia MR, et al. Chronic suppressive antibiotic treatment for staphylococcal bone and joint implant-related infections. Antibiotics. 2023;12:937. https:\/\/doi.org\/10.3390\/antibiotics12050937.","journal-title":"Antibiotics"},{"key":"1324_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jpids\/piad089","volume":"13","author":"CR Woods","year":"2024","unstructured":"Woods CR, Bradley JS, Chatterjee A, Kronman MP, Arnold SR, Robinson J, et al. Clinical practice guideline by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA): 2023 guideline on diagnosis and management of acute bacterial arthritis in pediatrics. J Pediatr Infect Dis Soc. 2024;13:1\u201359. https:\/\/doi.org\/10.1093\/jpids\/piad089.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"1324_CR131","doi-asserted-by":"publisher","first-page":"S463","DOI":"10.1016\/j.arth.2018.09.032","volume":"34","author":"R Anem\u00fcller","year":"2019","unstructured":"Anem\u00fcller R, Belden K, Brause B, Citak M, Del Pozo JL, Frommelt L, et al. Hip and knee section, treatment, antimicrobials: proceedings of International Consensus on Orthopedic Infections. J Arthroplasty. 2019;34:S463\u201375. https:\/\/doi.org\/10.1016\/j.arth.2018.09.032.","journal-title":"J Arthroplasty"},{"key":"1324_CR132","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/jpids\/piab027","volume":"10","author":"CR Woods","year":"2021","unstructured":"Woods CR, Bradley JS, Chatterjee A, Copley LA, Robinson J, Kronman MP, et al. Clinical practice guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics. J Pediatr Infect Dis Soc. 2021;10:801\u201344. https:\/\/doi.org\/10.1093\/jpids\/piab027.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"1324_CR133","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlz085","volume":"1","author":"S Hughes","year":"2019","unstructured":"Hughes S, Chin HY, Heard KL, Kamranpour P, Bartholomew B, Mughal N, et al. Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study. JAC-Antimicrob Resist. 2019;1:dlz085. https:\/\/doi.org\/10.1093\/jacamr\/dlz085.","journal-title":"JAC-Antimicrob Resist"},{"key":"1324_CR134","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1086\/381972","volume":"38","author":"GA Pankey","year":"2004","unstructured":"Pankey GA, Sabath LD. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram\u2010positive bacterial infections. Clin Infect Dis. 2004;38:864\u201370. https:\/\/doi.org\/10.1086\/381972.","journal-title":"Clin Infect Dis"},{"key":"1324_CR135","doi-asserted-by":"publisher","first-page":"i47","DOI":"10.1093\/jac\/dku252","volume":"69","author":"L Morata","year":"2014","unstructured":"Morata L, Tornero E, Martinez-Pastor JC, Garcia-Ramiro S, Mensa J, Soriano A. Clinical experience with linezolid for the treatment of orthopaedic implant infections. J Antimicrob Chemother. 2014;69:i47-52. https:\/\/doi.org\/10.1093\/jac\/dku252.","journal-title":"J Antimicrob Chemother"},{"key":"1324_CR136","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01282-23","volume":"0","author":"LG Miller","year":"2023","unstructured":"Miller LG, Flores EA, Launer B, Lee P, Kalkat P, Derrah K, et al. Safety and tolerability of tedizolid as oral treatment for bone and joint infections. Microbiol Spectr. 2023;0:e01282-23. https:\/\/doi.org\/10.1128\/spectrum.01282-23.","journal-title":"Microbiol Spectr"},{"key":"1324_CR137","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.19.1537","volume":"279","author":"W Zimmerli","year":"1998","unstructured":"Zimmerli W. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections a randomized controlled trial. JAMA. 1998;279:1537. https:\/\/doi.org\/10.1001\/jama.279.19.1537.","journal-title":"JAMA"},{"key":"1324_CR138","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s10096-017-3094-5","volume":"36","author":"J Courjon","year":"2017","unstructured":"Courjon J, Demonchy E, Cua E, Bernard E, Roger P-M. Efficacy and safety of clindamycin-based treatment for bone and joint infections: a cohort study. Eur J Clin Microbiol Infect Dis. 2017;36:2513\u20138. https:\/\/doi.org\/10.1007\/s10096-017-3094-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1324_CR139","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae328","author":"R Lecomte","year":"2024","unstructured":"Lecomte R, Deschanvres C, Le Bourgeois A, Bart G, Mahieu R, Le Moal G, et al. Efficacy and safety of co-trimoxazole in device-related bone and joint infections: a CRIOGO multicentre case\u2013control study. J Antimicrob Chemother. 2024. https:\/\/doi.org\/10.1093\/jac\/dkae328.","journal-title":"J Antimicrob Chemother"},{"key":"1324_CR140","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3947\/ic.2021.0144","volume":"54","author":"V Pratama","year":"2022","unstructured":"Pratama V, Risni HW, Yunir E, Sauriasari R. A systematic review of randomized controlled trials of antibiotic use in diabetic foot ulcer infections: focus on clinical cure. Infect Chemother. 2022;54:125\u201339. https:\/\/doi.org\/10.3947\/ic.2021.0144.","journal-title":"Infect Chemother"},{"key":"1324_CR141","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jinf.2006.11.011","volume":"54","author":"NG Daver","year":"2007","unstructured":"Daver NG, Shelburne SA, Atmar RL, Giordano TP, Stager CE, Reitman CA, et al. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis. J Infect. 2007;54:539\u201344. https:\/\/doi.org\/10.1016\/j.jinf.2006.11.011.","journal-title":"J Infect"},{"key":"1324_CR142","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1086\/516150","volume":"25","author":"JP Rissing","year":"1997","unstructured":"Rissing JP. Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones. Clin Infect Dis. 1997;25:1327\u201333. https:\/\/doi.org\/10.1086\/516150.","journal-title":"Clin Infect Dis"},{"key":"1324_CR143","doi-asserted-by":"publisher","first-page":"279","DOI":"10.5194\/jbji-7-279-2022","volume":"7","author":"E Giannitsioti","year":"2022","unstructured":"Giannitsioti E, Salles MJ, Mavrogenis A, Rodriguez-Pardo D, Los-Arcos I, Ribera A, et al. Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study. J Bone Joint Infect. 2022;7:279\u201388. https:\/\/doi.org\/10.5194\/jbji-7-279-2022.","journal-title":"J Bone Joint Infect"},{"key":"1324_CR144","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ijantimicag.2018.10.018","volume":"53","author":"A Papadopoulos","year":"2019","unstructured":"Papadopoulos A, Ribera A, Mavrogenis AF, Rodriguez-Pardo D, Bonnet E, Salles MJ, et al. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: role of surgery and impact of colistin administration. Int J Antimicrob Agents. 2019;53:294\u2013301. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.10.018.","journal-title":"Int J Antimicrob Agents"},{"key":"1324_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106763","volume":"61","author":"S-S Jean","year":"2023","unstructured":"Jean S-S, Liu I-M, Hsieh P-C, Kuo D-H, Liu Y-L, Hsueh P-R. Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria. Int J Antimicrob Agents. 2023;61:106763. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106763.","journal-title":"Int J Antimicrob Agents"},{"key":"1324_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1185602","author":"A Ruiz-Sancho","year":"2023","unstructured":"Ruiz-Sancho A, N\u00fa\u00f1ez-N\u00fa\u00f1ez M, Castelo-Corral L, Mart\u00ednez-Marcos FJ, Lois-Mart\u00ednez N, Abdul-Aziz MH, et al. Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1185602.","journal-title":"Front Pharmacol"},{"key":"1324_CR147","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab351","volume":"8","author":"T Ferry","year":"2021","unstructured":"Ferry T, Conrad A, Senneville E, Roux S, Dupieux-Chabert C, Dinh A, et al. Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant gram-positive pathogens: results from the TediSAT cohort study. Open Forum Infect Dis. 2021;8:ofab351. https:\/\/doi.org\/10.1093\/ofid\/ofab351.","journal-title":"Open Forum Infect Dis"},{"key":"1324_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106243","author":"L Carpenter","year":"2024","unstructured":"Carpenter L, Miller S, Flynn E, Choo JM, Collins J, Shoubridge AP, et al. Exposure to doxycycline increases risk of carrying a broad range of enteric antimicrobial resistance determinants in an elderly cohort. J Infect. 2024. https:\/\/doi.org\/10.1016\/j.jinf.2024.106243.","journal-title":"J Infect"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01324-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01324-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01324-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:34:12Z","timestamp":1777484052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01324-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01324-5","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Paul Laffont-Lozes has received support for attending meetings and\/or travel from Shionogi. Romaric Larcher has received consulting fees from MSD, payment or honoraria for lectures, presentations, speakers\u2019 bureaus, or educational events from BioM\u00e9rieux, MSD, Pfizer and Shionogi, and support for attending meetings and\/or travel from BioM\u00e9rieux, Roche Diagnostics, MSD, Pfizer and Shionogi. Agathe Artiaga has nothing to disclose. Jean-Philippe Lavigne has nothing to disclose. Paul\u00a0Loubet has received payment or honoraria for lectures, presentations, speakers\u2019 bureaus, or educational events from AstraZeneca, GSK, Janssen, MSD, Moderna, Pfizer, Sanofi Pasteur, and support for attending meetings and\/or travel from AstraZeneca, Pfizer, and Sanofi Pasteur. Albert\u00a0Sotto has received consulting fees from Besins Healthcare and Karo Pharma, support for attending meetings and\/or travel from Pfizer and MSD and participates free of charge on advisory boards of Biofilm Control and CTX Laboratory.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}